These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2394511)

  • 1. CA 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers.
    Ferroni P; Szpak C; Greiner JW; Simpson JF; Guadagni F; Johnston WW; Colcher D
    Int J Cancer; 1990 Sep; 46(3):445-51. PubMed ID: 2394511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoradiometric assay of CA 125 in effusions. Comparison with carcinoembryonic antigen.
    Pinto MM; Bernstein LH; Brogan DA; Criscuolo E
    Cancer; 1987 Jan; 59(2):218-22. PubMed ID: 3467816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.
    Ferrer J; Villarino MA; Encabo G; Felip E; Bermejo B; Vilà S; Orriols R
    Cancer; 1999 Oct; 86(8):1488-95. PubMed ID: 10526277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated antigens in effusions of malignant and benign origin.
    Ammon A; Eiffert H; Reil S; Beyer JH; Droese M; Hiddemann W
    Clin Investig; 1993 Jun; 71(6):437-44. PubMed ID: 8353402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour associated antigens in diagnosis of serous effusions.
    Mezger J; Permanetter W; Gerbes AL; Wilmanns W; Lamerz R
    J Clin Pathol; 1988 Jun; 41(6):633-43. PubMed ID: 2454957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic significance of the tumour markers CEA, CA 15-3 and CA 125 in malignant effusions in breast cancer.
    Kandylis K; Vassilomanolakis M; Baziotis N; Papadimitriou A; Tsoussis S; Ferderigou A; Efremidis AP
    Ann Oncol; 1990 Nov; 1(6):435-8. PubMed ID: 2083187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4.
    Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
    Lung Cancer; 2003 Jun; 40(3):289-94. PubMed ID: 12781427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEA and CA 549 in serum and pleural fluid of patients with pleural effusion.
    Hernández L; Espasa A; Fernández C; Candela A; Martín C; Romero S
    Lung Cancer; 2002 Apr; 36(1):83-9. PubMed ID: 11891038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
    Wang XF; Wu YH; Wang MS; Wang YS
    Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
    Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
    Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic efficiency of carcinoembryonic antigen and CA125 in the cytological evaluation of effusions.
    Pinto MM; Bernstein LH; Rudolph RA; Brogan DA; Rosman M
    Arch Pathol Lab Med; 1992 Jun; 116(6):626-31. PubMed ID: 1616424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions.
    Alataş F; Alataş O; Metintaş M; Colak O; Harmanci E; Demir S
    Lung Cancer; 2001 Jan; 31(1):9-16. PubMed ID: 11162861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma.
    Shijubo N; Honda Y; Fujishima T; Takahashi H; Kodama T; Kuroki Y; Akino T; Abe S
    Eur Respir J; 1995 Mar; 8(3):403-6. PubMed ID: 7789485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of the simultaneous determination of tumor markers in fluid and serum and their ratio in the differential diagnosis of serous effusions.
    Trapé J; Molina R; Sant F
    Tumour Biol; 2004; 25(5-6):276-81. PubMed ID: 15627892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of MCA, CA 15-3, CEA and CA-125 for discrimination between metastatic breast cancer and adenocarcinoma of other primary sites.
    De Wit R; Hoek FJ; Bakker PJ; Veenhof CH
    J Intern Med; 1991 May; 229(5):463-6. PubMed ID: 2040873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor markers in the diagnosis of malignant serous effusions.
    Cascinu S; Del Ferro E; Barbanti I; Ligi M; Fedeli A; Catalano G
    Am J Clin Oncol; 1997 Jun; 20(3):247-50. PubMed ID: 9167746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
    Salama G; Miédougé M; Rouzaud P; Mauduyt MA; Pujazon MC; Vincent C; Carles P; Serre G
    Br J Cancer; 1998; 77(3):472-6. PubMed ID: 9472646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor markers in pleural effusion diagnosis.
    Tamura S; Nishigaki T; Moriwaki Y; Fujioka H; Nakano T; Fujii J; Yamamoto T; Nabeshima K; Hada T; Higashino K
    Cancer; 1988 Jan; 61(2):298-302. PubMed ID: 3275487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.